Re: Letter Amendment to Promotion AgreementPromotion Agreement • November 7th, 2024 • Siga Technologies Inc • Pharmaceutical preparations
Reference is hereby made to that certain Promotion Agreement, dated as of May 31, 2019 (as amended prior to the date hereof, the “Agreement”), by and between SIGA Technologies, LLC. (“SIGA”) and Meridian Medical Technologies, Inc. (“MMT”) (each, a “Party” and, collectively, the “Parties”). Capitalized terms used but not otherwise defined in this letter (this “Letter Amendment”) have their meanings set forth in the Agreement.
AMENDMENT #1 CONSULTING AGREEMENTConsulting Agreement • November 7th, 2024 • Siga Technologies Inc • Pharmaceutical preparations
This Amendment #1 to the Consulting Agreement dated October 19, 2020 (this “Amendment”), is entered into and effective September 1, 2022 (“Amendment Effective Date”) by SIGA Technologies, Inc., a Delaware corporation with a principal address at, 31 East 62nd Street New York, NY 10065 (hereinafter “SIGA”), and Tides Group LLC, with a principal address at [***] (hereinafter “Consultant”) (each of SIGA and Consultant, a “Party” and, collectively, the “Parties”).
CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY "[***]," HAS BEEN OMITTED BECAUSE IT IS BOTH (1) NOT MATERIALAND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. CONSULTING AGREEMENT with SIGA Technologies, Inc.Consulting Agreement • November 7th, 2024 • Siga Technologies Inc • Pharmaceutical preparations • New York
This Agreement is made and entered into as of the date of date of last signature below (the “Effective Date”), by and between SIGA Technologies, Inc., a Delaware corporation having its principal offices at 31 East 62nd Street, New York, NY 10065, USA ( “SIGA”), and Tides Group, LLC having a place of business at [***] (“Consultant”). SIGA and Consultant are sometimes referred to herein individually as a “Party” and collectively as “the Parties”.
